Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06898749 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impact of Canine Mediation Practice in Psychomotor Therapy on Improving the Quality of Life in Adult Epileptic Patients.

Study acronym: MCP-Epi
StatusNot Yet Recruiting
PhaseNot applicable
Started2026-01
View on ClinicalTrials.gov ↗

Amendment history

2025-12-09
minor
Study Status, Sponsor/Collaborators, Oversight v3
Primary completion date2029-04→2029-06
Completion date2029-04→2029-06
Start date2025-10→2026-01
Collaborators-17 characters
Institut La Teppe
2025-07-03
minor
Study Status v2
Primary completion date2028-12→2029-04
Completion date2028-12→2029-04
Start date2025-06→2025-10
2025-03-31
minor
Study Status, Study Description v1
Re-verified, no change to tracked fields
2025-03-21
minor
Original filing
In addition to the search for new pharmaceutical or surgical solutions that could improve the therapeutic management of epileptic individuals, it is interesting to ask whether other complementary approaches, such as canine mediation in psychomotor therapy, could enhance the quality of life in this population. However, there is currently no evidence indicating that exposure to animals through mediation sessions would be beneficial for epileptic individuals, particularly regarding their quality of life, anxiety, emotional management, or cognition (such as social cognition). In the absence of current data in this population, it seems pertinent to study the impact of this practice on people with epilepsy. Furthermore, beyond quality of life, it would be valuable to examine whether it also influences anxiety or the frequency of seizures in individuals with epilepsy (a phenomenon reported for epileptic individuals living with a pet dog or a service dog). Canine mediation could help better manage and regulate the emotions of epileptic individuals, as well as improve their self-esteem.
Trial Details
NCT Number NCT06898749
Lead Sponsor Fondation Ophtalmologique Adolphe de Rothschild
Conditions Epilepsy
Enrollment 76 participants
Start Date 2026-01
Primary Completion 2029-06 (estimated)
Study Completion 2029-06 (estimated)
Updated on ClinicalTrials.gov 2025-12-17